Effects of rosuvastatin on the levels of blood glucose, blood lipid and hypersensitive C-reactive protein in patients with hypertension

Banerjee Y. Is prolong use of statins associated with increase in the risk of diabetes [J]. Journal of the American College of Cardiology, 2013(9):989.

Sattar N. Revisiting the links between glycaemia, diabetes and cardiovascular disease [J]. Diabetologia, 2013(4):686.

《中国高血压防治指南修订》委员会. 中国高血压防治指南(2010) [J]. 中华心血管病杂志, 2011(7):579.doi: 10.3760/cma.j.issn.0253-3758.2011.07.002.

Selwyn A P. Antiatherosclerotic effects of stains:LDL versus non-LDL effects [J]. Cunt Atheroscler Rep, 2007(4):281.

Libby P. Inflammatory mechanisms:the molecular basis of inflammation and disease [J]. Nutrition Reviews, 2007, (12):S140.

Virdis A, Schiffrin E L. Vascular inflammation:a role in vascular disease in hypertension [J]. Curr Opin in Nephrol and Hypertens, 2003(2):181.

Jones P H, Davidson M H, Stein E A. Comparison of the efficacy and safety of rosuvastatin versus atorvastatin, simvastatin, and pravastatin across doses [J]. American Journal of Cardiology, 2003(2):152.

Ray K K, Cannon C P, Cairns R. Relationship between uncontrolled risk factors and C-reactive protein levels in patients receiving standard or intensive statin therapy for acute coronary syndromes in the PROVE IT-TIMI 22 trial [J]. Journal of the American College of Cardiology, 2005(8):1417.

徐琴玉. 瑞舒伐他汀对高血压合并高脂血症患者超敏C反应蛋白及血脂的影响 [J]. 实用预防医学, 2010, (11):2264.doi: 10.3969/j.issn.1006-3110.2010.11.054.

Sattar N, Preiss D, Murray H M. Statinsand risk of incident diabetes:a collaborative meta-analysis of randomized statin trials [J]. The Lancet, 2010, (9716):735.

Preiss D, Seshasai S R, Welsh P. Risk of incident diabetes with intensive-dose compared with moderate-dose statin therapy:a meta-analysis [J]. Journal of the American Medical Association, 2011, (24):2556.

Izzo R, de Simone G, Trimarco V. Primary prevention with statins and incident diabetes in hypertensive patients at high cardiovascular risk [J]. Nutrition Metabolism and Cardiovascular Diseases, 2013.S0939-4753(12)00258-X.

Ridker P M, Danielson E, Fonseca F A. Rosuvastatin to prevent vascular events in men and women with elevated C reactive protein [J]. New England Journal of Medicine, 2008, (21):2195.